In an op-ed published in RealClearHealth, Gabriel Groisman, Chair of the Children’s Tumor Foundation, calls attention to the recent elimination of a critical rare disease research program by the Pentagon. This program has been instrumental in driving scientific breakthroughs for NF, leading to FDA-approved treatments and attracting key industry partners. Groisman urges Washington, DC to act swiftly and restore full funding to this smart, life-saving science.
Let Your Voice Be Heard
CTF launched a letter-writing advocacy platform that makes it easy for you to contact your representatives and make your voice heard.
